Winnipeg, MB – July 13, 2016 – Instead of a cloak of invisibility hiding a person in television and movies, a new method that describes mounting many imaging sensors underneath a flexible substrate could reveal tumors within humans or animals. Cubresa Inc., a medical imaging company that develops and markets nuclear imaging systems, today announced…

Cubresa’s NuPET™ scanner enables simultaneous preclinical molecular & functional imaging. The PET (Positron Emission Tomography) scanner inserts into existing MRI (Magnetic Resonance Imaging) systems and can speed drug development and clarify disease mechanisms for biomedical researchers. Cancer researchers can better understand tumors using Cubresa’s NuPET™ PET scanner with an MRI to see and measure responses…

A new video on the MTS Talks website features Cubresa Founder and CTO James Schallenberg and CEO George Abe describe their work at Cubresa and their experience doing business in the Manitoba work environment, the healthcare industry and within a supportive community. They also offer some advice to aspiring entrepreneurs. MTS Talks says the two leaders “pack a punch in…

In a recent Globe & Mail article “Winnipeg: Canada’s unlikely economic sweet spot”, Cubresa is mentioned as part of an extremely diversified economy that powers the Manitoba provincial economy, an economy that no longer depends on a single natural resource. Cubresa board member, David Asper is quoted in the article. A lawyer and businessman, Asper plays a leading…
Cubresa’s NuPET™ scanner enables simultaneous preclinical molecular & functional imaging. The PET (Positron Emission Tomography) scanner inserts into existing MRI (Magnetic Resonance Imaging) systems and can speed drug development and clarify disease mechanisms for biomedical researchers. Winnipeg, MB – April 26, 2016 – A compact PET scanner called NuPET™ has been commercially released for simultaneous preclinical…
Cubresa Exhibited at the ISMRM 24th Annual Meeting & Exhibition in Singapore Thank you for visiting us in Booth 519 at the Suntec Convention & Exhibition Centre in Singapore, May 7 to 13, 2016 where we introduced our NuPET™ in-bore PET scanner for existing pre-clinical MRI systems. See our media release on the release of NuPET. Make an…
Empowering biomedical researchers with richer, more comprehensive imaging data to combat disease, Cubresa Inc. today announced its MR Compatible Small Animal PET Scanner.
April 7, 2015
Cambridge MA – April 7, 2015 – To help researchers understand diseases that are difficult to diagnose like cancer and Alzheimer’s, an innovative Canadian preclinical imaging device company known as Cubresa has immersed itself in the intellectually-rich Massachusetts life sciences sector by opening the doors of its U.S. office in the Cambridge Innovation Center.
Winnipeg, Manitoba – July 21st, 2014 – Cubresa today announced it will exhibit its Spark compact SPECT scanner at the World Molecular Imaging Congress (WMIC), September 17th through September 20th in Seoul, Korea. Attendees are invited to visit the Cubresa booth (#413) in the exhibition hall to learn more.
Cubresa today announced it will debut its novel Spark preclinical SPECT scanner at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, June 8 – June 10th in St. Louis, Missouri. Attendees are invited to visit booth #503 in the exhibition hall to learn more about the product. The Spark SPECT scanner for…
A fast and affordable way to add SPECT to an existing small animal CT scanner WINNIPEG, Manitoba – April 16th, 2014 – Today Cubresa introduced a new compact, affordable SPECT scanner for preclinical research. The scanner attaches to existing small animal CT systems, transforming them into multi-modality molecular imaging systems for disease study, translational research…
September 21, 2013
Cubresa today announced that it has moved to larger office and manufacturing space at 1393 Border Street in Winnipeg, Manitoba, Canada. “This increased space is a testament to our advancing relationship with our customers and the investment that we are receiving from our community” said James Schellenberg, CEO and Founder of Cubresa.

Cubresa is a world leader in the design and development of clinical and preclinical PET inserts for MRI. Cubresa products enable medical professionals at leading universities, hospitals and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.